Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a 'living drug' – Los Angeles Times
Los Angeles Times |
Hailing a breakthrough in fighting cancer, FDA approves gene therapy that functions as a ‘living drug’
Los Angeles Times The new cancer treatment, called Kymriah, involves reprogramming a patient’s T cells in the laboratory so that they are better equipped to fight cancer. The genetically modified cells are multiplied in the lab before being infused into the patient … US clears breakthrough gene therapy for childhood leukemia FDA announces first US gene therapy approval for cancer treatment FDA Approves First Gene-Altering Leukemia Treatment, Costing $475000 |
View original article
Author:
Powered by WPeMatico